1
|
Antezana PE, Municoy S, Bellino MG, Martini MF, Desimone MF. Nanodelivery of the Gramicidin Peptide for Enhancing Antimicrobial Activity. EUR J LIPID SCI TECH 2021. [DOI: 10.1002/ejlt.202000389] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Pablo E. Antezana
- Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) Facultad de Farmacia y Bioquímica Junín 956, (1113) Buenos Aires Argentina
| | - Sofia Municoy
- Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) Facultad de Farmacia y Bioquímica Junín 956, (1113) Buenos Aires Argentina
| | - Martín G. Bellino
- Instituto de Nanociencia y Nanotecnología – Comisión Nacional de Energía Atómica y Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Av. General Paz 1499, (1650) San Martín Argentina
| | - M. Florencia Martini
- Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) Facultad de Farmacia y Bioquímica Junín 956, (1113) Buenos Aires Argentina
| | - Martín F. Desimone
- Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) Facultad de Farmacia y Bioquímica Junín 956, (1113) Buenos Aires Argentina
| |
Collapse
|
2
|
Gaiser RA, Ayerra Mangado J, Mechkarska M, Kaman WE, van Baarlen P, Conlon JM, Wells JM. Selection of antimicrobial frog peptides and temporin-1DRa analogues for treatment of bacterial infections based on their cytotoxicity and differential activity against pathogens. Chem Biol Drug Des 2020; 96:1103-1113. [PMID: 31102497 PMCID: PMC7891380 DOI: 10.1111/cbdd.13569] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Revised: 04/27/2019] [Accepted: 05/05/2019] [Indexed: 01/02/2023]
Abstract
Cationic, amphipathic, α-helical host-defense peptides (HDPs) that are naturally secreted by certain species of frogs (Anura) possess potent broad-spectrum antimicrobial activity and show therapeutic potential as alternatives to treat infections by multidrug-resistant pathogens. Fourteen amphibian skin peptides and twelve analogues of temporin-1DRa were studied for their antimicrobial activities against clinically relevant human or animal skin infection-associated pathogens. For comparison, antimicrobial potencies of frog skin peptides against a range of probiotic lactobacilli were determined. We used the VITEK 2 system to define a profile of antibiotic susceptibility for the bacterial panel. The minimal inhibitory concentration (MIC) values of the naturally occurring temporin-1DRa, CPF-AM1, alyteserin-1c, hymenochirin-2B, and hymenochirin-4B for pathogenic bacteria were threefold to ninefold lower than the values for the tested probiotic strains. Similarly, temporin-1DRa and its [Lys4 ], [Lys5 ], and [Aib8 ] analogues showed fivefold to 6.5-fold greater potency against the pathogens. In the case of PGLa-AM1, XT-7, temporin-1DRa and its [D-Lys8 ] and [Aib13 ] analogues, no apoptosis or necrosis was detected in human peripheral blood mononuclear cells at concentrations below or above the MIC. Given the differential activity against commensal bacteria and pathogens, some of these peptides are promising candidates for further development into therapeutics for topical treatment of skin infections.
Collapse
Affiliation(s)
- Rogier A Gaiser
- Host-Microbe Interactomics Group, Animal Sciences Department, Wageningen University, Wageningen, The Netherlands
| | - Jaione Ayerra Mangado
- Host-Microbe Interactomics Group, Animal Sciences Department, Wageningen University, Wageningen, The Netherlands
| | - Milena Mechkarska
- Department of Biochemistry, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
| | - Wendy E Kaman
- Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre Rotterdam (EMC), Rotterdam, The Netherlands
| | - Peter van Baarlen
- Host-Microbe Interactomics Group, Animal Sciences Department, Wageningen University, Wageningen, The Netherlands
| | - J Michael Conlon
- Department of Biochemistry, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
| | - Jerry M Wells
- Host-Microbe Interactomics Group, Animal Sciences Department, Wageningen University, Wageningen, The Netherlands
| |
Collapse
|
3
|
Rodrigues GR, López-Abarrategui C, de la Serna Gómez I, Dias SC, Otero-González AJ, Franco OL. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Int J Pharm 2018; 555:356-367. [PMID: 30453018 DOI: 10.1016/j.ijpharm.2018.11.043] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2018] [Revised: 11/13/2018] [Accepted: 11/15/2018] [Indexed: 01/07/2023]
Abstract
In the last years, the antimicrobial resistance against antibiotics has become a serious health issue, arise as global threat. This has generated a search for new strategies in the progress of new antimicrobial therapies. In this context, different nanosystems with antimicrobial properties have been studied. Specifically, magnetic nanoparticles seem to be very attractive due to their relatively simple synthesis, intrinsic antimicrobial activity, low toxicity and high versatility. Iron oxide NPs (IONPs) was authorized by the World Health Organization for human used in biomedical applications such as in vivo drug delivery systems, magnetic guided therapy and contrast agent for magnetic resonance imaging have been widely documented. Furthermore, the antimicrobial activity of different magnetic nanoparticles has recently been demonstrated. This review elucidates the recent progress of IONPs in drug delivery systems and focuses on the treatment of infectious diseases and target the possible detrimental biological effects and associated safety issues.
Collapse
Affiliation(s)
- Gisele Regina Rodrigues
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil
| | | | - Inés de la Serna Gómez
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil
| | - Simoni Campos Dias
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil
| | | | - Octavio Luiz Franco
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil; S-Inova Biotech, Post-Graduate in Biotechnology, Catholic University Dom Bosco, Campo Grande, Brazil.
| |
Collapse
|
4
|
Bueno J. Fungal Bionanotechnology, When Knowledge Merge into a New Discipline to Combat Antimicrobial Resistance. Fungal Biol 2017. [DOI: 10.1007/978-3-319-68424-6_10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Lopez-Abarrategui C, Figueroa-Espi V, Lugo-Alvarez MB, Pereira CD, Garay H, Barbosa JA, Falcão R, Jiménez-Hernández L, Estévez-Hernández O, Reguera E, Franco OL, Dias SC, Otero-Gonzalez AJ. The intrinsic antimicrobial activity of citric acid-coated manganese ferrite nanoparticles is enhanced after conjugation with the antifungal peptide Cm-p5. Int J Nanomedicine 2016; 11:3849-57. [PMID: 27563243 PMCID: PMC4984987 DOI: 10.2147/ijn.s107561] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Diseases caused by bacterial and fungal pathogens are among the major health problems in the world. Newer antimicrobial therapies based on novel molecules urgently need to be developed, and this includes the antimicrobial peptides. In spite of the potential of antimicrobial peptides, very few of them were able to be successfully developed into therapeutics. The major problems they present are molecule stability, toxicity in host cells, and production costs. A novel strategy to overcome these obstacles is conjugation to nanomaterial preparations. The antimicrobial activity of different types of nanoparticles has been previously demonstrated. Specifically, magnetic nanoparticles have been widely studied in biomedicine due to their physicochemical properties. The citric acid-modified manganese ferrite nanoparticles used in this study were characterized by high-resolution transmission electron microscopy, which confirmed the formation of nanocrystals of approximately 5 nm diameter. These nanoparticles were able to inhibit Candida albicans growth in vitro. The minimal inhibitory concentration was 250 µg/mL. However, the nanoparticles were not capable of inhibiting Gram-negative bacteria (Escherichia coli) or Gram-positive bacteria (Staphylococcus aureus). Finally, an antifungal peptide (Cm-p5) from the sea animal Cenchritis muricatus (Gastropoda: Littorinidae) was conjugated to the modified manganese ferrite nanoparticles. The antifungal activity of the conjugated nanoparticles was higher than their bulk counterparts, showing a minimal inhibitory concentration of 100 µg/mL. This conjugate proved to be nontoxic to a macrophage cell line at concentrations that showed antimicrobial activity.
Collapse
Affiliation(s)
| | - Viviana Figueroa-Espi
- Lab of Structural Analysis, Institute of Materials Science and Technology, Havana University, La Habana, Havana, Cuba
| | | | - Caroline D Pereira
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil
| | - Hilda Garay
- Laboratory of Peptide Analysis and Synthesis, Center of Genetic Engineering and Biotechnology, La Habana, Havana, Cuba
| | - João Arg Barbosa
- Department of Cellular Biology, Laboratory of Biophysics, Institute of Biological Science, University of Brasilia
| | - Rosana Falcão
- Brazilian Agricultural Research Corporation (EMBRAPA), Center of Genetic Resources and Biotechnology (CENARGEN), Brasilia DF, Brazil
| | - Linnavel Jiménez-Hernández
- Lab of Structural Analysis, Institute of Materials Science and Technology, Havana University, La Habana, Havana, Cuba
| | - Osvaldo Estévez-Hernández
- Lab of Structural Analysis, Institute of Materials Science and Technology, Havana University, La Habana, Havana, Cuba; Instituto de Ciencia y Tecnología de Materiales (IMRE), Universidad de La Habana, Cuba
| | - Edilso Reguera
- Research Center for Applied Science and Advanced Technology (CICATA), National Polytechnic Institute (IPN), Lagaria Unit, Mexico DF, Mexico
| | - Octavio L Franco
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil; S-Inova Biotech, Post-Graduate in Biotechnology, Universidade Catolica Dom Bosco, Campo Grande, Brazil
| | - Simoni C Dias
- Center for Biochemical and Proteomics Analyses, Catholic University of Brasilia, Brasilia, Brazil
| | | |
Collapse
|